ductal carcinoma in situ


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia.
Related to ductal carcinoma in situ: lobular carcinoma in situ

ductal carcinoma in situ

Intraductal carcinoma, DIN 3 Surgical oncology A localized form of breast CA, in which malignant cells are confined to the duct wall; DCIS has a heterogeneous biologic behavior and morphology, and is detectable by mammography Epidemiology DCIS has ↑–2/105–1973 to 14/105–1992; it accounts for 12% of breast CAs–US Subtypes
1. Low nuclear grade without central necrosis–low to minimal risk of recurrence after wide excision.
2. High nuclear grade with central necrosis–high recurrence despite RT and complete–conservative excision Management Lumpectomy, lumpectomy with RT, or by mastectomy.

Patient discussion about ductal carcinoma in situ

Q. Hi all. I was diagnosed with DCIS in April. Had a lumpectomy about 3 cm and it was removed. Am I cured fully? Hi all. I was diagnosed with DCIS in April. Had a lumpectomy about 3 cm and it was removed. I then had 28 radiation and 4 boosters. I went to the cancer center for my checkup and the doctor said nothing to worry. They didn’t advice me further follow up and I am normal for the past 6 months and not even taking tamoxifen. I am quite normal like others. Am I cured fully?

A. Hey nothing to worry!! Early diagnosis is half cured. The same thing applies to your case. With early diagnosis and treatment, the doctors should have removed the cancer parts with the surgery. Based on the report they have given you radiation and other meds. If you be estrogen +ve then they would have given you it as a preventive. By the way if you have any doubts better approach your doctor and have your checkup done as a precautionary measure.

Q. My wife is diagnosed with DCIS type of breast cancer. My wife is diagnosed with DCIS type of breast cancer. Doctors had staged my wife`s cancer as low. She is still due for some tests which she will soon have. Doctor have told that there is nothing much to worry so why are they taking so many tests?

A. All the tests are taken to confirm about the type of treatment to be given. These pre treatment tests can avoid the risk of post treatment complications. Even if the complications arise they will know the best possible course of counter treatment. So please cooperate with the doctor.
http://www.youtube.com/watch?v=y2kl_eOWEtc&eurl=http://www.imedix.com/health_community/vy2kl%5EeOWEtc_nurse_sandy_interview_1_breast_cancer?q=dcis%20type%20of%20b&feature=player_embedded

More discussions about ductal carcinoma in situ
References in periodicals archive ?
Twenty five percent of the 183,000 new cases of breast cancer occurring each year are diagnosed as Ductal Carcinoma in situ or DCIS -- the earliest stage of breast cancer.
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up.
Identification of a basal-like subtype of breast ductal carcinoma in situ.
Women who were screened annually had the highest frequency of ductal carcinoma in situ and T1 tumors at diagnosis.
Food and Drug Administration (FDA) has granted a six-month priority review to AstraZeneca's breast cancer drug NOLVADEX(R) (tamoxifen citrate) for the adjuvant treatment of ductal carcinoma in situ (DCIS) in women following breast surgery and radiation.
Lobular carcinoma in situ (LCIS) was defined as a lesion in which more than 50% of the acini of a terminal duct--lobular unit were dilated and completely filled by uniform, small, and dyscohesive cells with bland nuclei, uniform chromatin, and indistinct nucleoli, whereas ductal carcinoma in situ (DCIS) was characterized by a single cell population showing cytologic pleomorphism, presence of mitoses, or singlecell necrosis and an appropriate growth pattern in at least 2 duct spaces.
Samples from normal or fibrocystic breasts and those with atypical hyperplasia or ductal carcinoma in situ did not synthesize RhoC.
Next came ductoscopy, which showed the precise location of a white nodular lesion of ductal carcinoma in situ.
The College of American Pathologists published the recommended protocol for examination of specimens and reporting ductal carcinoma in situ (DCIS) of the breast in the January issue of the Archives of Pathology & Laboratory Medicine.
Ductal carcinoma in situ was found in five patients; most of these appeared as papillary exophytic lesions.
2) As pointed out by the authors, the extent of ductal carcinoma in situ (DCIS) is an important prognostic factor for local recurrence after segmental resection.
The only cancer missed on MRI was a ductal carcinoma in situ.